Patrick J Mulchrone
CIK 1812174 · View on SEC EDGAR ↗
First SEC filing: May 14, 2020 · Latest: May 27, 2022
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 25, 2026 | CME | A | 645 | $225.00 | $145,125 | 29,130 Direct | +2.26% | Acquired | 19.9% (price as of 2026-08-19) |
| June 25, 2025 | CME | A | 532 | $273.03 | $145,252 | 28,485 Direct | +1.90% | Acquired | -1.2% (price as of 2026-08-19) |
| June 25, 2024 | CME | A | 748 | $194.10 | $145,187 | 27,953 Direct | +2.75% | Acquired | 39.0% (price as of 2026-08-19) |
| June 26, 2023 | CME | A | 811 | $178.89 | $145,080 | 27,205 Direct | +3.07% | Acquired | 50.9% (price as of 2026-08-19) |
| June 27, 2022 | CME | A | 693 | $209.44 | $145,142 | 26,394 Direct | +2.70% | Acquired | 28.8% (price as of 2026-08-19) |
| Jan. 25, 2022 | CME | A | 47 | $221.79 | $10,424 | 50,701 Direct | +0.09% | Acquired | 21.7% (price as of 2026-08-19) |
| June 25, 2021 | CME | A | 551 | $218.12 | $120,184 | 50,654 Direct | +1.10% | Acquired | 23.7% (price as of 2026-08-19) |
| June 25, 2020 | CME | A | 712 | — | — | 50,103 Direct | +1.44% | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 14, 2020 | CME | Class B Common Stock, Series B-1 | 1 | Direct |
| May 14, 2020 | CME | Class B Common Stock, Series B-2 | 1 | Direct |
| May 14, 2020 | CME | Class B Common Stock, Series B-3 | 1 | Direct |
| May 14, 2020 | CME | Class B Common Stock, Series B-4 | 1 | Direct |
| May 14, 2020 | CME | Common Stock Class A | 49,391 | Direct |